Drug Discovery (Phylogica)
The Drug Discovery Technology Group and Phylogica, commercialisation vehicle.
Addressing emerging needs of the
The Drug Discovery Technology Group is focused on developing new therapies to target disease-causing interactions between proteins; both inside and outside of cells, especially targets driving childhood cancer.
The research of the unit is funded by contracts with several large pharmaceutical companies via a commercial entity named 'Phylogica,' which was the first spin-off company from the Telethon Kids Institute.
Listed on the Australian Stock Exchange, Phylogica (PYC) is a specialist drug discovery company, which identifies new prototype drugs for large drug company customers. It achieves this by drawing from its own source of billions of unique natural peptide compounds - a new drug class known as "Phylomers".
This collection of more than 400 billion compounds is the source
of its potential new drugs and access to this asset is what has
driven deals and strategic alliances with the international
pharmaceutical giants Roche, MedImmune (AstraZeneca), Pfizer,
Janssen Biotech (Johnson &Johnson) and Genetech within the last
These unique collections of Phylomer peptides are strongly protected by a portfolio of 18 patent families, including granted patents in the US and Europe.
Dr Douglas Wilson, Executive Chairman
Dr Graham Boden. CFO
Dr Richard Hopkins, Program Manager- Drug Discovery Unit. CEO Phylogica.
Dr Paul Watt, Senior Principal Program Manager & Head of Drug Discovery Unit. CSO Phylogica
Dr Katrin Hoffmann, Associate Program Manager - Drug Discovery Unit. Director of Research Operations - Phylogica
Dr Paula Cunningham, Senior Research Officer - Drug Discovery Unit. Group Leader, Bioassay Development - Phylogica
Dr Tatjana Heinrich, Associate Program Manager - Drug Discovery Unit. Group Leader, Intracellular Screening and Library Development - Phylogica
Dr Nadia Milech, Associate Program Manager - Drug Discovery Unit. Group Leader, Intracellular Screening and Library Development - Phylogica
Senior Scientists, Drug Discovery
Dr Renae Barr
Dr Heique Bogdawa
Dr Rob Dewhurst
Dr Suzy Juraja
Dr Brooke Longville
Dr Shane Stone
Dr Yew-Foon Tan
Mr Mark Anastasas
Ms Laura Florez
Ms Maria Kerfoot
Ms Marie Scobie , Lab Manager
Mr Scott Winslow
Ms Leanne Neville
Ms Farzana Khan, Office Manager
Ms Angela Purkiss, Administrative Assistant